News
Lundbeck on track to meet financial expectations and renew...
H. Lundbeck A/S (Lundbeck) reports first half revenue of DKK 6,829 million, excluding Lexapro® in the US, an increase of 1% compared to the...
News
Bristol-Myers Squibb Foundation awards $1.6 million in grants
The Bristol-Myers Squibb Foundation announced $1.6 million in grants to four health care institutions in India that will help improve diabetes education, prevention and...
News
AcelRx sufentanil NanoTab pain products gain additional US patents
The US Patent and Trademark Office (USPTO) has issued two additional patents to AcelRx Pharmaceuticals' sufentanil NanoTab pain products. Â The patent...
News
Rejected Alzheimer’s drug shows new potential
An international team of scientists led by researchers at Mount Sinai School Medicine have discovered that a drug that had previously yielded conflicting results in...
News
Trial signals major milestone in hunt for new TB...
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found...
News
Roche reports second positive study of RoACTEMRA given by...
Roche announced that the BREVACTA study of RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) given as a subcutaneous (SC) injection to patients with rheumatoid arthritis...
News
Novartis begins shipment of Fluvirin influenza seasonal vaccine in...
Novartis has commenced shipment of Fluvirin influenza vaccine for the 2012-2013 influenza season, in the US. Novartis plans to ship more than...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.